Correlation Between GlaxoSmithKline PLC and Elevation Series

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Elevation Series at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Elevation Series into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Elevation Series Trust, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Elevation Series and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Elevation Series. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Elevation Series.

Diversification Opportunities for GlaxoSmithKline PLC and Elevation Series

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between GlaxoSmithKline and Elevation is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Elevation Series Trust in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Series Trust and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Elevation Series. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Series Trust has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Elevation Series go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Elevation Series

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Elevation Series. In addition to that, GlaxoSmithKline PLC is 1.75 times more volatile than Elevation Series Trust. It trades about -0.3 of its total potential returns per unit of risk. Elevation Series Trust is currently generating about 0.09 per unit of volatility. If you would invest  6,019  in Elevation Series Trust on August 30, 2024 and sell it today you would earn a total of  93.00  from holding Elevation Series Trust or generate 1.55% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Elevation Series Trust

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Elevation Series Trust 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Elevation Series Trust has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable technical indicators, Elevation Series is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

GlaxoSmithKline PLC and Elevation Series Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Elevation Series

The main advantage of trading using opposite GlaxoSmithKline PLC and Elevation Series positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Elevation Series can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Series will offset losses from the drop in Elevation Series' long position.
The idea behind GlaxoSmithKline PLC ADR and Elevation Series Trust pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data